| Survival: | 8.8 months |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | Vepesid |
| Country: | Netherlands |
| City/State/Province: | Amsterdam |
| Hospital: | University Hospital Vrije Universiteit |
| Journal: | Link |
| Date: | 11/1997 |
| Description: |
| Patients: This Phase II trial involved 41 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of a chemotherapy drug, oral etoposide (VP 16-213, vepesid).Toxicity: Grade 3-4 toxicities included hematological, nausea/vomiting, cutaneous reaction, and alopecia.Results: Median survival was 38 weeks (8.8 months). |